Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -111.2% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 2.3 | n/a |
Pr/Book | 0.4 |
Latest | F'cast | |
---|---|---|
Revenue | -77.3% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-18 | 13.72 | (2.08) | (6.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | 11.47 | (3.43) | (8.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 277.20 | 165.17 | 194.00p | 4.4 | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 92.60 | (5.66) | (9.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 21.04 | (20.05) | (31.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
DHSC Claim update – Pre-Trial Review | 19-Apr-2024 | 07:00 | RNS |
Directorate Changes and FY 23 results update | 11-Apr-2024 | 07:00 | RNS |
Liquidity Agreement and Total Voting Rights | 02-Apr-2024 | 16:00 | RNS |
Novacyt gearing up for hearing in DHSC litigation | 19-Apr-2024 | ShareCast |
Novacyt confirms end of Yourgene Taiwan disposal... | 06-Feb-2024 | ShareCast |
Novacyt taps Steve Gibson for CFO | 02-Jan-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 70.00p |
Change Today | 5.60p |
% Change | 8.70 % |
52 Week High | 80.30 |
52 Week Low | 36.90 |
Volume | 404,023 |
Shares Issued | 70.63m |
Market Cap | £49.44m |
RiskGrade | 453 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 15 @ 70.00p |
16:35 | 13 @ 70.00p |
16:35 | 2 @ 70.00p |
16:29 | 690 @ 72.49p |
16:28 | 206 @ 72.50p |
You are here: research